Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 300.00
Bid: 298.50
Ask: 301.50
Change: 13.00 (4.53%)
Spread: 3.00 (1.005%)
Open: 280.50
High: 304.50
Low: 280.50
Prev. Close: 287.00
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS: Deutsche raises GSK; HSBC cuts BP to Hold

Thu, 24th Jun 2021 09:49

(Alliance News) - The following London-listed shares received analyst recommendations Thursday and Wednesday:

----------

FTSE 100

----------

DEUTSCHE BANK RAISES GLAXOSMITHKLINE TO 'HOLD' (SELL) - PRICE TARGET 1,350 (1,300) PENCE

----------

CREDIT SUISSE RAISES GLAXOSMITHKLINE PRICE TARGET TO 1,400 (1,300) PENCE - 'UNDERPERFORM'

----------

UBS RAISES SAINSBURY PRICE TARGET TO 290 (275) PENCE - 'BUY'

----------

BOFA RAISES DIAGEO PRICE TARGET TO 4,150 (3,900) PENCE - 'BUY'

----------

BERENBERG RAISES CRODA INTERNATIONAL PRICE TARGET TO 7,800 (7,400) PENCE - 'BUY'

----------

BERENBERG INITIATES PHOENIX GROUP WITH 'HOLD' - TARGET 790 PENCE

----------

CREDIT SUISSE RAISES NATWEST PRICE TARGET TO 260 (247) PENCE - 'OUTPERFORM'

----------

UBS RAISES BERKELEY GROUP PRICE TARGET TO 5,400 (5,240) PENCE - 'BUY'

----------

JEFFERIES CUTS CRH PRICE TARGET TO 4,449 (4,549) PENCE - 'BUY'

----------

CREDIT SUISSE RAISES DS SMITH PRICE TARGET TO 470 (450) PENCE - 'NEUTRAL'

----------

HSBC CUTS BP TO 'HOLD' (BUY) - PRICE TARGET 360 (365) PENCE

----------

CREDIT SUISSE CUTS SEVERN TRENT PRICE TARGET TO 2,310 (2,340) PENCE - 'NEUTRAL'

----------

FTSE 250

----------

HSBC RAISES IMI TO 'BUY' ('HOLD') - TARGET 2,065 (1,370) PENCE

----------

JPMORGAN CUTS WOOD GROUP PRICE TARGET TO 340 (350) PENCE - 'OVERWEIGHT'

----------

BERENBERG RAISES TRAVIS PERKINS PRICE TARGET TO 2050 (1910) PENCE - 'BUY'

----------

BERNSTEIN RAISES ROYAL MAIL PRICE TARGET TO 650 (575) PENCE - 'MARKET-PERFORM'

----------

BERENBERG INITIATES BEAZLEY WITH 'HOLD' - TARGET 410 PENCE

----------

BERENBERG RAISES CINEWORLD GROUP PRICE TARGET TO 85 (70) PENCE - 'HOLD'

----------

BARCLAYS RAISES WORKSPACE GROUP PRICE TARGET TO 745 (700) PENCE - 'UNDERWEIGHT'

----------

JEFFERIES RAISES OXFORD BIOMEDICA PRICE TARGET TO 1,180 (950) PENCE - 'HOLD'

----------

OTHER MAIN MARKET AND AIM

----------

BERENBERG RAISES NEXT FIFTEEN COMMUNICATIONS TARGET TO 1,140 (940) PENCE - 'BUY'

----------

JEFFERIES RAISES KERRY GROUP PRICE TARGET TO 130 (127) EUR - 'BUY'

----------

RBC RAISES SMART METERING PRICE TARGET TO 1,060 (950) PENCE - 'OUTPERFORM'

----------

BERENBERG RAISES VICTORIA PRICE TARGET TO 1,110 (1,050) PENCE - 'BUY'

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
21 Sep 2021 09:14

UPDATE 2-FTSE 100 recovers 1% on energy, healthcare stock boost; Entain jumps

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* Kingfisher top FTSE 100 loser despite positive results* Royal Dutch Shell sells U.S. oilfield assets* Stagecoast surges on merger talks wit...

Read more
15 Sep 2021 16:05

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
6 Aug 2021 10:55

ReNeuron taps Oxford Biomedica executive Catherine Isted as CFO

ReNeuron taps Oxford Biomedica executive Catherine Isted as CFO

Read more
28 Jul 2021 12:49

UK wants world vaccinated by middle of 2022, Raab says

OXFORD, England, July 28 (Reuters) - British Foreign Secretary Dominic Raab warned that the world would not be vaccinated until 2024 under current rates and urged other countries to join Britain in donating shots to poorer nations to bring that d...

Read more
15 Jul 2021 14:54

EXECUTIVE CHANGES: Oxford BioMedica adds former Teva exec to board

EXECUTIVE CHANGES: Oxford BioMedica adds former Teva exec to board

Read more
15 Jul 2021 09:45

BROKER RATINGS: Citigroup prefers Beazley over Hiscox and Lancashire

BROKER RATINGS: Citigroup prefers Beazley over Hiscox and Lancashire

Read more
6 Jul 2021 15:52

IN BRIEF: Oxford BioMedica exec sells shares after options exercise

IN BRIEF: Oxford BioMedica exec sells shares after options exercise

Read more
21 Jun 2021 09:34

BROKER RATINGS: UBS cuts Rio Tinto to Sell; Morgan Stanley ups Ocado

BROKER RATINGS: UBS cuts Rio Tinto to Sell; Morgan Stanley ups Ocado

Read more
18 Jun 2021 14:26

AstraZeneca must use Britain's plant if needed to meet EU's vaccine commitments - EU lawyer

June 18 (Reuters) - AstraZeneca must deliver COVID-19 vaccines to the European Union also from a factory in Britain if it is needed to meet its commitments with the EU, a judge ruled on Friday, according to a lawyer representing the EU.The company...

Read more
18 Jun 2021 14:06

UPDATE 5-EU loses bid for speedier AstraZeneca vaccine deliveries

* Judge orders AstraZeneca to deliver doses by strict deadlines* EU had asked for more doses to be shipped earlier* AstraZeneca may have breached contract in reserving doses for UK* Second legal case will establish whether contract was breached (...

Read more
28 May 2021 19:41

TRADING UPDATES: Odyssean IT swings to profit; BMO Cap ups dividend

TRADING UPDATES: Odyssean IT swings to profit; BMO Cap ups dividend

Read more
27 May 2021 17:27

EXECUTIVE CHANGES: Vectura senior director departs amid takeover offer

EXECUTIVE CHANGES: Vectura senior director departs amid takeover offer

Read more
25 May 2021 15:50

DIRECTOR DEALINGS: Renalytix AI CEO sells USD2 million in shares

DIRECTOR DEALINGS: Renalytix AI CEO sells USD2 million in shares

Read more
25 May 2021 09:35

BROKER RATINGS: Royal Mail boosted to Buy from Hold by Peel Hunt

BROKER RATINGS: Royal Mail boosted to Buy from Hold by Peel Hunt

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.